Earnings Call · Q4 FY2022·2023-02-21

Q4 22EPS +46.15%·Rev n/aQ3 22EPS +25.00%·Rev n/aQ2 22EPS +44.00%·Rev n/aQ1 22EPS +2.86%·Rev n/a⚠ consensus missing

Elanco Animal Health Inc ELAN

Katy Grissom — Head of Investor Relations

Jeff Simmons — President and Chief Executive Officer

Todd Young — Chief Financial Officer

−11.5%1d on move date−9.5% vs SPY3d−8.1%5d−11.7%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ELAN calls or request research access.

More ELAN calls Browse calls Request research access